Alternative Splicing in the HumanPMP22Gene: Implications in CMT1A Neuropathy
- 21 October 2015
- journal article
- research article
- Published by Hindawi Limited in Human Mutation
- Vol. 37 (1) , 98-109
Abstract
CMT1A patients commonly share PMP22 genetic overloading but they show phenotypic heterogeneity and variability in PMP22 mRNA and protein expression. Moreover, PMP22 mRNA levels do not correlate with clinical outcome measures in these patients, suggesting their uselessness as a disease biomarker. Thus, in-depth analysis of PMP22 transcription and translation might help to define its pathogenic role in CMT1A. We focused on the alternative splicing of PMP22 gene to verify whether mRNA processing is altered in CMT1A. We identified three new PMP22 transcripts enriched in human sural nerve biopsies. One of them was an untranslated variant, whereas the other two originated from a PMP22 undescribed exon and encoded for a new putative protein localized in the endoplasmic reticulum. As splicing events in the PMP22 gene are differently regulated in tissues and during development, we analyzed the levels of PMP22 transcripts and their splicing pattern in human and experimental CMT1A. We found an altered PMP22 splicing ratio in the CMT1A rat. In addition, we showed a remarkable derangement in rat QKI expression, which is a critical regulator of splicing during myelination. Overall, our data suggest that an alteration of mRNA processing could be a pathogenic mechanism in CMT1A.Keywords
This publication has 67 references indexed in Scilit:
- The Palmitoylation State of PMP22 Modulates Epithelial Cell Morphology and MigrationASN Neuro, 2012
- The QKI‐PLP pathway controls SIRT2 abundance in CNS myelinGlia, 2011
- Ascorbic acid in Charcot–Marie–Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trialThe Lancet Neurology, 2011
- Quaking I controls a unique cytoplasmic pathway that regulates alternative splicing of myelin-associated glycoproteinProceedings of the National Academy of Sciences, 2010
- Mechanisms for Nonrecurrent Genomic Rearrangements Associated with CMT1A or HNPP: Rare CNVs as a Cause for Missing HeritabilityThe American Journal of Human Genetics, 2010
- P2X7-mediated Increased Intracellular Calcium Causes Functional Derangement in Schwann Cells from Rats with CMT1A NeuropathyJournal of Biological Chemistry, 2009
- Peripheral myelin protein 22 is regulated post‐transcriptionally by miRNA‐29aGlia, 2009
- Molecular mechanisms of inherited demyelinating neuropathiesGlia, 2008
- Natural Gene-Expression Variation in Down Syndrome Modulates the Outcome of Gene-Dosage ImbalanceThe American Journal of Human Genetics, 2007
- Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophreniaProceedings of the National Academy of Sciences, 2006